PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-89.54%
Both yoy net incomes decline, with EQT at -89.08%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.22%
D&A growth of 1.22% while EQT is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-27.27%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
393.72%
Slight usage while EQT is negative at -88.58%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.98%
Some yoy usage while EQT is negative at -57.49%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-38.83%
Negative yoy while EQT is 23.47%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
37.95%
Some CFO growth while EQT is negative at -66.94%. John Neff would note a short-term liquidity lead over the competitor.
-24.36%
Negative yoy CapEx while EQT is 15.07%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
24525.00%
Acquisition spending well above EQT's 105.52%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
385.71%
Purchases growth of 385.71% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
24.36%
Liquidation growth of 24.36% while EQT is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-284.94%
We reduce yoy other investing while EQT is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-194.64%
We reduce yoy invests while EQT stands at 15.85%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-89.47%
Negative yoy issuance while EQT is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.